medigraphic.com

2019, Number 4

<< Back Next >>

Rev Clin Esc Med 2019; 9 (4)

Prevalencia de nefropatía en el paciente portador de virus de inmunodeficiencia humana en el servicio de infectología del hospital Rafael Ángel Calderón Guardia de Enero a Diciembre 2017

Arley VDA, Espinach RM

Language: Spanish
References: 18
Page: 50-63
PDF size: 1155.68 Kb.


ABSTRACT

HIV infection is highly prevalent worldwide. Renal disorders, both acute and chronic, are more common in patients with HIV than in the general population, being present in up to 30% of these patients. Patients with HIV infection can develop various glomerular, vascular, tubulointerstitial and obstructive nephropathies related in some cases to the virus itself, to the drugs administered or to the coinfections they present. Given this, it is important to determine the prevalence of nephropathy in patients with HIV in the health center. Objective: to determine the prevalence of patients with nephropathy in the HIV carrier population treated at the RACG Hospital. Population: patients in the infectology department Rafael Ángel Calderón Guardia Hospital. Methods: observational, retrospective study. A prevalence of 20% patients with chronic kidney disease of KDIGO 2 or more stages is documented; 2.5% of the population presented significant proteinuria unrelated to viral load or CD4 count. It is necessary to improve the control for the prevention and / or diagnosis of nephropathy in the patient with HIV in the infectology department of H. R. A. C. G.


REFERENCES

  1. Durak, D. (1981). Infecciones oportunistas y sarcoma de Kaposi en hombres homosexuales. N Engl J Med 1981; 305: 1465-1467, DOI: 10.1056 / NEJM198112103052408. Recuperado de: http://www. nejm.org/doi/full/10.1056/NEJM198112103052408

  2. Samji, J. et al.. (2013) Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada. PLoS ONE 8(12): e81355. doi:10.1371/journal.pone.0081355

  3. Tebit,D. (2011). Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease. Lancet Infect Dis 2011; 11: 45–56. DOI:10.1016/S1473-3099(10)70186-9

  4. Centers for Disease Control and Prevention. (2016). Division of HIV/AIDS Prevention. Estadisticas básicas. Recuperado de: https://www.cdc.gov/ hiv/spanish/basics/statistics.html

  5. Organización Mundial de la Salud. (2017). Nuevas directrices sobre el autoanálisis del VIH. Recuperado de: http://www.who.int/hiv/es/

  6. Ministerio de Salud de Costa Rica (2013). Informe Nacional sobre los avances en la lucha contra el Sida 2011-2013 San José, Costa Rica. Recuperado de: http://www.sidastudi.org/es/registro/ff808181463cc- 53c01466590970c004e

  7. Feinberg, J. et al. (2011). Management of Newly Diagnosed HIV Infection. Ann Intern Med. 2011;155(7):ITC4-1. DOI: 10.7326/0003-4819- 155-7-201110040-01004 Girón, J. et al. (2014). Protocolo diagnóstico diferencial de la nefropatía en un paciente con infección por el VIH. Medicine. 2014;11(49):2924-7.

  8. Campos, P. et al. (2016). HIV and kidney diseases: 35 years of history and consequences. Clinical Kidney Journal, 2016, 1–10. doi: 10.1093/ckj/sfw104

  9. Juega, J. et al. Prevalence, evolution, and related risk factors of kidney disease among Spanish HIVinfected individuals. Medicine (2017) 96:37(e7421). http://dx.doi.org/10.1097/MD.0000000000007421

  10. Bertoldi, A. et al. HIV and kidney: a dangerous liaison. New Microbiologica, 40, 1, 1-10, 2017, ISN 1121-7138. Recuperado de: http://www.newmicrobiologica. org/PUB/allegati_pdf/2017/1/1.pdf

  11. Loens, C. et al. Nephrotoxicity of antiretrovirals other than tenofovir. Nephrologie & The´rapeutique 14 (2018) 55–66. https://doi.org/10.1016/j. nephro.2017.12.001

  12. Rosenberg, A. Z. et al. Nat. Rev. Nephrol. 11, 150–160 (2015); published online 17 February 2015; doi:10.1038/nrneph.2015.9

  13. Nobakht, E. et al. HIV-associated immune complex kidney disease. NATURE REVIEWS | NEPHROLOGY VOLUME 12 | MAY 2016 | 291. doi:10.1038/nrneph.2015.216

  14. European AIDS Clinical Society. GUÍA CLÍNICA. Versión 9. Octubre de 2017. Recuperado de: http:// www.eacsociety.org/files/guidlines-9.0-spanish.pdf

  15. Aberg, J. et al. Primary Care Guidelines for the Management of Persons InfectedWith HIV: 2013 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases 2014;58(1):e1–34. DOI: 10.1093/cid/cit665

  16. Lucas, G. et al. Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases 2014;59(9):e96–138. DOI: 10.1093/cid/ciu617.

  17. Górriz, J. et al. Consenso sobre el manejo de la patología renal en pacientes con infección por VIH. Nefrologia 2014;34(6): 768-88. Doi:10.3265/Nefrologia. pre2014.sep.12745.

  18. Ekrikpo UE, Kengne AP, Bello AK, Effa EE, Noubiap JJ, Salako BL, et al. (2018) Chronic kidney disease in the global adult HIV-infected population: A systematic review and meta-analysis. PLoS ONE 13(4): e0195443. https://doi.org/10.1371/journal. pone.0195443




2020     |     www.medigraphic.com